Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
191 Results Found
ASHRAE/ASHE Guideline 43
ASHRAE/ASHE Guideline 43, Operations Guideline for Ventilation of Health Care Facilities is here to help health care organizations during times when operationally ventilation systems need to function outside of the design requirements.
Regulatory Relief to Promote Domestic Production of Critical Medicines
Directs the Commissioner of the Food and Drug Administration to review and eliminate any duplicative or unnecessary requirements in regulations and guidance pertaining to the development of domestic pharmaceutical manufacturing within 180 days.
AHA Statement to House Energy & Commerce Subcommittee on Health Hearing for June 11, 2025
AHA statement for the record to the Committee on Energy and Commerce Health Subcommittee hearing “Made in America: Strengthening Domestic Manufacturing and the Health Care Supply Chain.”
Executive Summary: Tariffs and Their Impact on the U.S. Health Care Supply Chain
The U.S. health care system relies heavily on a global supply chain for pharmaceuticals and medical devices.
AHA Comments on the Proposed Change to Section 301 Tariffs for Goods Made in China – 90183100
June 28, 2024 The Honorable Katherine TaiU.S. Trade Representative600 17th Street NWWashington, DC 20508
AHA Senate Statement on Trade in Critical Supply Chains
AHA statement for the record to the Senate Committee on Finance regarding the importance of trade in critical supply chains.
AHA Urges Administration to Grant Exceptions for Current and Proposed Tariffs for Medications and Medical Supplies
The AHA late yesterday told the administration that its current and proposed tariffs on Canada, Mexico and China may jeopardize the availability of vital medications and essential health care devices.
AHA Comments on Commerce Department Investigation of Pharmaceutical Imports
AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on pharmaceutical and pharmaceutical ingredient imports.
Tariffs on Canada, China and Mexico
The White House issued Feb. 1 executive orders that impose tariffs on products from Canada, Mexico and China.